Dexamethasone but not indomethacin inhibits human phagocyte nicotinamide adenine dinucleotide phosphate oxidase activity by down-regulating expression of genes encoding oxidase components

Journal of Immunology

Volumn 161, Issue 9, 1998, Pages 4960-4967

  Condino Neto, Antonio ^a   Whitney, Constance ^b   Newburger, Peter E ^b  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GAMMA INTERFERON; INDOMETACIN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL DIFFERENTIATION; DRUG EFFECT; ELECTRON TRANSPORT; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; GENETIC REGULATION; HUMAN; HUMAN CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; RESPIRATORY BURST; TISSUE INJURY;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELLS, CULTURED; CYTOCHROME B GROUP; DEXAMETHASONE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INDOMETHACIN; INTERFERON TYPE II; LEUKEMIA, MONOCYTIC, ACUTE; MEMBRANE GLYCOPROTEINS; MONOCYTES; NADPH OXIDASE; NEOPLASM PROTEINS; PHOSPHOPROTEINS; SUPEROXIDES; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0032213274     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (104)

1. Henderson, L. M., and J. B. Chappell. 1996. NADPH oxidase of neutrophils. Biochim. Biophys. Acta 1273:87.
2. Chanock, S. J., J. El Benna, R. M. Smith, and B. M. Babior. 1994. The respiratory burst oxidase. J. Biol. Chem. 269:24519.
3. Curnutte, J. T., S. H. Orkin, and M. C. Dinauer. 1994. Genetic disorders of phagocyte function. In The Molecular Basis of Blood Diseases, 2nd Ed. G. Stamatoyannopoulos, A. W. Neinhuis, P. W. Majerus, and H. Varmus, eds. W. B. Saunders, Philadelphia, p. 493.
4. Quie, P. G. 1993. Chronic granulomatous disease of childhood: a saga of discovery and understanding. Pediatr. Infect. Dis. J. 12:395.
5. McCord, J. M., B. Gao, J. Leff, and S. C. Flores. 1994. Neutrophil-generated free radicals: possible mechanisms of injury in adult respiratory distress syndrome. Envirn. Health Perspect. 102(Suppl. 10):57.
6. Halliwell, B. 1995. Oxygen radicals, nitric oxide and human inflammatory joint disease. Ann. Rheum. Dis. 54:505.
7. Wiseman, H., and B. Halliwell. 1996. Damage to DNA by reactive oxygen and nitrogen species: role in inflammatory disease and progression to cancer. Biochem. J. 313:17.
8. Segal, A. W., O. T. G. Jones, D. Webster, and A. C. Allison. 1978. Absence of a newly described cytochrome b from neutrophils of patients with chronic granulomatous disease. Lancet ii:446.
9. Segal, A. W., and A. Abo. 1993. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18:43.
10. Jesaitis, A. J., E. S. Buescher, D. Harrison, M. T. Quinn, C. A. Parkos, S. Livesey, and J. Linner. 1990. Ultrastructural localization of cytochrome b in the membranes of resting and phagocytosing human granulocytes. J. Clin. Invest. 85:821.
11. Parkos, C. A., R. A. Allen, C. G. Cochrane, and A. J. Jesaitis. 1987. Purified cytochrome b from human granulocyte plasma membrane is comprised of two polypeptides of 91,000 and 22,000 relative molecular weights. J. Clin. Invest. 80:732.
12. Roos, D., M. de Boer, F. Kuribayashi, C. Meischl, R. S. Weening, A. W. Segal, A. Åhlin, K. Nemet, J. P. Hossle, E. Bernatowska-Matuszkiewicz, et al. 1996. Mutations in the X-linked and autosomal recessive forms of chronic granulomatous disease. Blood 87:1663.
13. Cross, A. R., J. T. Cumutte, J. Rae, and P. G. Heyworth. 1996. Hematologically important mutations: X-linked chronic granulomatous disease. Blood Cells Mol. Dis. 22:90.
14. Curnutte, J. T., P. J. Scott, and L. A. Mayo. 1989. Cytosolic components of the respiratory burst oxidase: resolution of four components, two of which are missing in complementing types of chronic granulomatous disease. Proc. Natl. Acad. Sci. USA 86:825.
15. McPhail, L. C., P. S. Shirley, C. C. Clayton, and R. Snyderman. 1985. Activation of the respiratory burst enzyme from human neutrophils in a cell-free system: evidence for a soluble cofactor. J. Clin. Invest. 75:1735.
16. Babior, B. M., R. Kuver, and J. T. Cumutte. 1988. Kinetics of activation of the respiratory burst oxidase in a fully soluble system from human neutrophils. J. Biol. Chem. 263:1713.
17. Leto, T. L., K. J. Lomax, B. D. Volpp, H. Nunoi, J. M. Sechler, W. M. Nauseef, R. A. Clark, J. I. Gallin, and H. L. Malech. 1990. Cloning of a 67-kD neutrophil oxidase factor with similarity to a noncatalytic region of p60c-src. Science 248: 727.
18. Lomax, K. J., T. L. Leto, H. Nunoi, J. I. Gallin, and H. L. Malech. 1989. Recombinant 47-kilodalton cytosol factor restores NADPH oxidase in chronic granulomatous disease. Science 245:409.
19. Volpp, B. D., W. M. Nauseef, and R. A. Clark. 1988. Two cytosolic neutrophil oxidase components absent in autosomal chronic granulomatous disease. Science 242:1295.
20. phax during neutrophil activation: phosphorylation of sites recognized by protein kinase C and by proline-directed kinases. J. Biol. Chem. 269:23431.
21. Quinn, M. T., C. A. Parkos, L. Walker, S. H. Orkin, M. C. Dinauer, and A. J. Jesaitis. 1989. Association of a Ras-related protein with cytochrome b of human neutrophils. Nature 342:198.
22. Gabig, T. G., C. D. Crean, P. L. Mantel, and R. Rosli. 1995. Function of wildtype or mutant Rac2 and Rap1a GTPases in differentiated HL60 cell NADPH oxidase activation. Blood 85:804.
23. Knaus, U. G., S. Morris, H.-J. Dong, J. Chernoff, and G. M. Bokoch. 1995. Regulation of human leukocyte p21-activated kinases through G protein-coupled receptors. Science 269:221.
24. Simon, M. C., L. Pevny, M. V. Wiles, G. Keller, F. Costantini, and S. H. Orkin. 1992. Rescue of erythroid development in gene targeted GATA-1 mouse embryonic stem cells. Nat. Genet. 1:92.
25. Zhan, S., N. Vazquez, F. B. Wientjes, M. L. Budarf, E. Schrock, T. Ried, E. D. Green, and S. J. Chanock. 1996. Genomic structure, chromosomal localization, start of transcription, and tissue expression of the human p40-phox, a new component of the nicotinamide adenine dinucleotide phosphate-oxidase complex. Blood 88:2714.
26. Newburger, P. E., R. A. B. Ezekowitz, C. Whitney, J. Wright, and S. H. Orkin. 1988. Induction of phagocyte cytochrome b heavy chain gene expression by interferon γ. Proc. Natl. Acad. Sci. USA 85:5215.
27. Newburger, P. E., Q. Dai, and C. Whitney. 1991. In vitro regulation of human phagocyte cytochrome b heavy and light chain gene expression by bacterial lipopolysaccharide and recombinant human cytokines. J. Biol. Chem. 266:16171.
28. Schwiebert, L. A., L. A. Beck, C. Stellato, C. A. Bickel, B. S. Bochner, and R. P. Schleimer. 1996. Glucocorticoid inhibition of cytokine production: relevance to antiallergic actions. J. Allergy Clin. Immunol. 97:143.
29. Haynes, R. C., Jr., and F. Murad. 1980. Adrenocorticotropic hormone: adrenocortical steroids and their synthetic analogs; inhibitors of adrenocortical steroid biosynthesis. In The Pharmacological Basis of Therapeutics, 6th ed. A. G. Gilman, L. S. Goodman, and A. Gilman, eds. Macmillan, New York, p. 1466.
30. Fukushima, K., M. Ando, K. Ito, M. Suga, and S. Araki. 1990. Stimulus-and cumulative dose-dependent inhibition of superoxide production by polymorphonuclear leukocytes of patients receiving corticosteroids. J. Clin. Lab. Immunol. 33:117.
31. Maridonneau-Parini, I., M. Errasfa, and F. Russo-Marie. 1989. Inhibition of superoxide generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages. J. Clin. Invest. 83:1936.
32. Schultz, R. M., S. K. W. Nanda, and M. G. Altom. 1985. Effects of various inhibitors of arachidonic acid oxygenation on macrophage superoxide release and tumoricidal activity. J. Immunol. 135:2040.
33. Roilides, E., K. Uhlig, D. Venson, P. A. Pizzo, and T. J. Walsh. 1993. Prevention of corticosteroid-induced suppression of human polymorphonuclear leukocyte-induced damage of Aspergillus fumigatus hyphae by granulocyte colony-stimulating factor and γ interferon. Infect. Immun. 61:4870.
34. Collado-Escobar, D., and F. Mollinedo. 1994. Dexamethasone modifies the functional responses of the granulocytic differentiating HL-60 cells. Biochem. J. 299:553.
35. Russo-Marie, F. 1992. Macrophages and the glucocorticoids. J. Neuroimmunol. 40:281.
36. Cox, G. 1995. Glucocorticoid treatment inhibits apoptosis in human neutrophils: separation of survival and activation outcomes. J. Immunol. 154:4719.
37. Chao, T. C., P. J. Van Alten, and R. J. Walter. 1994. Steroid sex hormones and macrophage function: modulation of reactive oxygen intermediates and nitrite release. Am. J. Reprod. Immunol. 32:43.
38. Heck, S., M. Kulimann, A. Gast, H. J. Rahmsdorf, P. Herrlich, and A. C. Cato. 1994. A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13:4087.
39. Adcock, I. M., H. Shirasaki, C. M. Gelder, M. J. Peters, C. R. Brown, and P. J. Barnes. 1994. The effects of glucocorticoids on phorbol ester and cytokine stimulated transcription factor activation in human lung. Life Sci. 55:1147.
40. Adcock, I. M., C. R. Brown, C. M. Gelder, H. Shirasaki, M. J. Peters, and P. J. Barnes. 1995. The effects of glucocorticoids on transcription factor activation in human peripheral blood mononuclear cells. Am. J. Physiol. 37:331.
41. Ray, A., and K. E. Prefontaine. 1994. Physical association and functional antagonism between the p65 subunit of transcription factor NF-κB and the glucocorticoid receptor. Proc. Natl. Acad Sci. USA 91:752.
42. Sheinman, R. I., P. C. Cogswell, A. K. Lofquist, and A. S. Baldwin, Jr. 1995. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science 270:283.
43. Auphan, N., J. A. DiDonato, C. Rosette, A. Helmberg, and M. Karin. 1995. Immunosuppression by glucocorticoids: Inhibition of NF-κB activity through induction of IκB synthesis. Science 270:286.
44. Flower, R. J., S. Moncada, and J. R. Vane. 1980. Drug therapy of inflammation. In The Pharmacological Basis of Therapeutics, 6th ed. A. G. Gilman, L. S. Goodman, and A. Gilman, eds. Macmillan, New York, p. 682.
45. Ferreira, S. H., S. Moncada, and J. R. Vane. 1971. Indomethacin and aspirin abolish prostaglandin release from the spleen. Nature 231:237.
46. Smith, J. B., and A. L. Willis. 1971. Aspirin selectively inhibits prostaglandin production in human platelets. Nature 231:235.
47. Vane, J. R. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232.
48. Cotto, J. J., M. Kline, and R. I. Morimoto. 1996. Activation of heat shock factor I DNA binding precedes stress-induced serine phosphorylation: evidence for a multistep pathway of regulation. J. Biol. Chem. 271:3355.
49. Amici, C., A. Rossi, and M. G. Santoro. 1995. Aspirin enhances thermotolerance in human erythroleukemic cells: an effect associated with the modulation of the heat shock response. Cancer Res. 55:4452.
50. Chen, L. Y., D. L. Lawson, and J. L. Mehta. 1994. Reduction in human neutrophil superoxide anion generation by n-3 polyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor. Thromb. Res. 76:317.
51. Neumuller, J., and M. Tohidast-Akrad. 1994. Comparative in vitro investigations of the influence of mofebutazone, phenylbutazone, and diclofenac on phagocytosis and respiratory burst of human peripheral blood leucocytes. Arzneim.-Forsch. 44:636.
52. Haynes, D. R., P. F. Wright, S. J. Gadd, M. W. Whitehouse, and B. Vernon-Roberts. 1993. Is aspirin a prodrug for antioxidant and cytokine-modulating oxymetabolites? Agents Actions 39:49.
53. Twomey, B. M., and M. M. Dale. 1992. Cyclooxygenase-independent effects of non-steroidal anti-inflammatory drugs on the neutrophil respiratory burst. Biochem. Pharmacol. 43:413.
54. Yagisawa, M., A. You, M. Yonemaru, S. Imajoh-Ohmi, S. Kanegasaki, Y. Yazaki, and F. Takaku. 1996. Superoxide release and NADPH oxidase components in mature human phagocytes: correlation between functional capacity and amount of functional proteins. Biochem. Biophys. Res. Commun. 228:510.
55. Ezekowitz, R. A. B., S. H. Orkin, and P. E. Newburger. 1987. Recombinant interferon 7 augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease. J. Clin. Invest. 80:1009.
56. Ezekowitz, R. A. B., M. C. Dinauer, H. S. Jaffe, S. H. Orkin, and P. E. Newburger. 1988. Partial correction of the phagocyte defect in patients with X-linked chronic granulomatous disease by subcutaneous interferon γ. N. Engl. J. Med. 319:146.
57. Tsuchiya, S., M. Yamabe, Y. Yamaguchi, Y. Kobayashi, T. Konno, and K. Tada. 1980. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J. Cancer 26:171.
58. Tsuchiya, S., Y. Kobayashi, Y. Goto, H. Okumura, S. Nakae, T. Konno, and K. Tada. 1982. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42:1530.
59. Flower, R. J., and G. J. Blackwell. 1979. Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456.
60. Hirata, F., Y. Notsu, M. Iwata, L. Parente, M. di Rosa, and R. J. Flower. 1982. Identification of several species of phospholipase inhibitory protein(s) by radioimmunoassay for lipomodulin. Biochem. Biophys. Res. Commun. 109:223.
61. Lau, C. K., W. C. Black, M. Belley, C. Chan, S. Charleson, D. Denis, J. Y. Gauthier, R. Gordon, D. Guay, P. Hamel, et al. 1997. From indomethacin to a selective COX-2 inhibitor: development of indolalkanoic acids as potent and selective cyclooxygenase-2 inhibitors. Adv. Exp. Med. Biol. 407:73.
62. Riendeau, D., S. Charleson, W. Cromlish, J. A. Mancini, E. Wong, and J. Guay. 1997. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays. Can. J. Physiol. Pharmacol. 75:1088.
63. McCord, J., and I. Fridovich. 1969. Superoxide dismutase: An enzymatic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:6044.
64. 558 in polymorphonuclear leukocytes and macrophages in the presence of hemoglobin or mitochondrial cytochromes. Anal. Biochem. 175:22.
65. Ginsburg, D., R. I. Handin, D. T. Bonthron, T. A. Donlon, G. A. P. Bruns, S. A. Latt, and S. H. Orkin. 1985. Human von Willebrand factor: isolation of complementary DNA clones and chromosomal location. Science 228:1401.
66. Maniatis, T., E. F. Fritsch, and J. Sambrook. 1990. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY.
67. Royer-Pokora, B., L. M. Kunkel, A. P. Monaco, S. C. Goff, P. E. Newburger, R. L. Baehner, F. S. Cole, J. T. Curnutte, and S. H. Orkin. 1986. Cloning the gene for an inherited disorder-chronic granulomatous disease - on the basis of its chromosomal location. Nature 322:32.
68. Gatti, R. A., P. Concannon, and W. Salser. 1984. Multiple use of Southern blots. BioTechniques 2:148.
69. Katz, R. A., B. F. Erlanger, and R. V. Guntaka. 1983. Evidence for extensive methylation of ribosomal RNA genes in a rat XC cell line. Biochim. Biophys. Acta 739:258.
70. Newburger, P. E., C. Speier, N. Borregaard, C. E. Walsh, J. C. Whitin, and E. R. Simons. 1984. Development of the superoxide-generating system during differentiation of the HL-60 promyelocytic leukemia cell line. J. Biol. Chem. 259:3771.
71. Greenberg, M. E., L. A. Greene, and E. B. Ziff. 1985. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. J. Biol. Chem. 260:14101.
72. Krowczynska, A., R. Yenofsky, and G. Brawerman. 1985. Regulation of messenger RNA stability in mouse erythroleukemia cells. J. Mol. Biol. 181:231.
73. Emerson, J. D., and H. Strenio. 1983. Boxplots and batch comparison. In Understanding Robust and Exploratory Data Analysis. D. C. Hoaglin, F. Mosteller, and J. M. Tukey, eds. John Wiley & Sons, New York, p. 58.
74. Bhattacharyya, G. K., and R. A. Johnson. 1977. Nonparametric inference. In Statistical Concepts and Methods. G. K. Bhattacharyya and R. A. Johnson, eds. John Wiley & Sons, Singapore, p. 505.
75. Condino-Neto, A., C. Whitney, and P. E. Newburger. 1996. The effect of dexamethasone or indomethacin on cytochrome b expression and superoxide production by human myelomonocytic THP-1 cells differentiated by IFN-γ and/or TNF-α. Blood 88:29b (Abstr.).
76. Almawi, W. Y., H. N. Beyhum, A. A. Rahme, and M. J. Rieder. 1996. Regulation of cytokine and cytokine receptor expression by glucocorticoids. J. Leukocyte Biol. 60:563.
77. Gatanaga, T., C. D. Hwang, M. Gatanaga, F. Cappuccini, R. S. Yamamoto, and G. A. Granger. 1991. The regulation of TNF receptor mRNA synthesis, membrane expression, and release by PMA-and LPS-stimulated human monocytic THP-1 cells in vitro. Cell Immunol. 138:1.
78. Krakauer, T., and J. J. Oppenheim. 1993. IL-1 and tumor necrosis factor-α each up-regulate both the expression of IFN-γ receptors and enhance IFN-γ-induced HLA-DR expression on human monocytes and a human monocytic cell line (THP-1). J. Immunol. 150:1205.
79. Fushimi, T., H. Okayama, T. Seki, S. Shimura, and K. Shirato. 1997. Dexamethasone suppressed gene expression and production of interleukin-10 by human peripheral blood mononuclear cells and monocytes. Int. Arch. Allergy Immunol. 112:13.
80. Lew, W., J. J. Oppenheim, and K. Matsushima. 1988. Analysis of the suppression of IL-1α and IL-1β production in human peripheral blood mononuclear adherent cells by a glucocorticoid hormone. J. Immunol. 140:1895.
81. Boumpas, D. T., E. D. Anastassiou, S. A. Older, G. C. Tsokkos, D. L. Nelson, and J. E. Balow. 1991. Dexamethasone inhibits human IL-2 but not IL-2 receptor gene expression in vitro at the level of nuclear transcription. J. Clin. Invest. 87:1739.
82. Culpepper, J. A., and F. Lee. 1985. Regulation of IL-3 expression by glucocorticoids in cloned murine T lymphocytes. J. Immunol. 135:3191.
83. Wu, C. Y., C. Fargeas, T. Nakajima, and G. Delespesse. 1991. Glucocorticoids suppress the production of interleukin-4 by human lymphocytes. Eur. J. Immunol. 21:2645.
84. Rolfe, F. G., J. M. Hughes, C. L. Armour, and W. A. Sewell. 1992. Inhibition of interleukin-5 gene expression by dexamethasone. Immunology 77:494.
85. Waage, A., G. Slupphaug, and R. Shalaby. 1990. Glucocorticoids inhibit the production of IL-6 from monocytes, endothelial cells and fibroblasts. Eur. J. Immunol. 20:2439.
86. Tobler, A., R. Meier, M. Seitz, B. Dewald, M. Baggiolini, and M. F. Fey. 1992. Glucocorticoids downregulate gene expression of GM-CSF. NAP/IL-8 and IL-6, but not of M-CSF, in human fibroblasts. Blood 79:45.
87. Waage, A., and O. Bakke. 1988. Glucocorticoids suppress the production of tumour necrosis factor by lipopolysaccharide-stimulated human monocytes. Immunology 63:299.
88. Arya, S. K., F. Wong-Staal, and R. C. Gallo. 1984. Dexamethasone-mediated inhibition of human T cell growth factor and γ-interferon mRNA. J. Immunol. 133:273.
89. Hass, R., M. Brach, S. Kharbanda, G. Giese, P. Traub, and D. Kufe. 1991. Inhibition of phorbol ester-induced monocytic differentiation by dexamethasone is associated with down-regulation of c-fos and c-jun (AP-1). J. Cell. Physiol. 149:125.
90. Hulley, P. A., F.-Gordon, and F. S. Hough. 1998. Inhibition of mitogen-activated protein kinase activity and proliferation of an early osteoblast cell line (MBA 15.4) by dexamethasone: role of protein phosphatases. Endocrinology 139:2423.
91. Hoff, T., T. Spencker, A. Emmendoerffer, and M. Goppelt-Struebe. 1992. Effects of glucocorticoids on the TPA-induced monocytic differentiation. J. Leukocyte Biol. 52:173.
92. Paliogianni, F., N. Hama, J. E. Balow, M. A. Valentine, and D. T. Boumpas. 1995. Glucocorticoid-mediated regulation of protein phosphorylation in primary human T cells: evidence for induction of phosphatase activity. J. Immunol. 155:1809.
93. Wang, Y., J. J. Zhang, K. Y. Lei, and J. W. Pike. 1997. Dexamethasone and interleukin-1 potently synergize to stimulate the production of granulocyte colony-stimulating factor in differentiated THP-1 cells. Biochem. Biophys. Res. Commun. 239:676.
94. Vachula, M., T. J. Holzer, K. E. Nelson, and B. R. Andersen. 1998. Effect of glucocorticoids and interferon-γ on the oxidative responses of monocytes from leprosy patients and normal donors. Int. J. Leprosy 59:41.
95. Costas, M., T. Trapp, M. P. Pereda, J. Sauer, R. Rupprecht, V. E. Nahmod, J. M. H. M. Reul, F. Holsboer, and E. Arzt. 1996. Molecular and functional evidence for in vitro cytokine enhancement of human and murine target cell sensitivity to glucocorticoids: TNF-α priming increases glucocorticoid inhibition of TNF-α-induced cytotoxicity/apoptosis. J. Clin. Invest. 98:1409.
96. 245 heavy chain gene expression and nicotinamide-adenine dinucleotide phosphate oxidase in human leukemic myeloid cells. J. Clin. Invest. 83:1570.
97. Forehand, J. R., M. J. Pabst, W. A. Phillips, and R. B. Johnston, Jr. 1989. Lipopolysaccharide priming of human neutrophils for an enhanced respiratory burst: role of intracellular free calcium. J. Clin. Invest. 83:74.
98. Berkow, R. L., and M. R. Dodson. 1988. Biochemical mechanisms involved in the priming of neutrophils by tumor necrosis factor. J. Leukocyte Biol. 44:345.
99. Johnston, J. J., P. Rintels, J. Chung, J. Sather, E. J. Benz, Jr., and N. Berliner. 1992. Lactoferrin gene promoter: structural integrity and nonexpression in HL60 cells. Blood 79:2998.
100. Woodman, R. C., J. T. Curnutte, and B. M. Babior. 1988. Evidence that de novo protein synthesis participates in a time-dependent augmentation of the chemotactic peptide-induced respiratory burst in neutrophils. Free Radical Biol. Med. 5:355.
101. Forrest, C. B., J. R. Forehand, R. A. Axtell, R. L. Roberts, and R. B. Johnston, Jr. 1988. Clinical features and current management of chronic granulomatous disease. Hematol./Oncol. Clin. North Am. 2:253.
102. Fischer, A., A. W. Segal, R. Seger, and R. S. Weening. 1993. The management of chronic granulomatous disease. Eur. J. Pediatr. 152:896.
103. Liese, J. G., V. Jendrossek, A. Jansson, T. Petropoulou, S. Kloos, M. Gahr, and B. H. Belohradsky. 1996. Chronic granulomatous disease in adults. Lancet 347: 220.
104. Kimura, K. 1997. Mechanisms of active oxygen species reduction by non-steroidal anti-inflammatory drugs. Int. J. Biochem. Cell. Biol. 29:437.